Key result
Familial dilated cardiomyopathy was associated with significantly worse six-year survival compared to non-familial forms (6% vs 23%, P<0.05).
Why the study?
Does familial dilated cardiomyopathy have an earlier onset and worse prognosis compared to non-familial dilated cardiomyopathy?
Cohort (n=240)
Does familial dilated cardiomyopathy have an earlier onset and worse prognosis compared to non-familial dilated cardiomyopathy?
Absolute Event Rate: 6% vs 23%
p-value: p=< 0.05
Familial dilated cardiomyopathy is a more malignant disease than sporadic forms, presenting at an earlier age and progressing more rapidly to death.
May support family screening in dilated cardiomyopathy; leaves open whether genotype-guided therapy improves survival.
OBJECTIVE: To establish the time of onset of dilated cardiomyopathy (DCM) by review of annual chest x rays, which are obligatory in Hungary. DESIGN: A retrospective survey of chest x rays of a cohort of confirmed cases of DCM, to assess time of onset of cardiomegaly. Clinical course was compared by follow up over a mean of six years from the time of diagnosis. SUBJECTS: 240 patients with DCM (31 familial, 209 non-familial). Diagnosis was made by echocardiography in all cases and confirmed by coronary angiography and heart biopsy in some cases. MAIN RESULTS: At diagnosis, the mean age of the patients was 31.8 years in the familial group and 39.6 years in the non-familial group (P < 0.05). The time between the onset of cardiomegaly (cardiothoracic ratio > 0.45) and clinical diagnosis was 8.0 and 10.1 years respectively (P < 0.05). The six year survival was 6% in the familial group and 23% in the non-familial group (P < 0.05). CONCLUSIONS: The familial form of DCM is the more malignant form: it occurs at an earlier age and progresses more rapidly than non-familial DCM.
No takes yet. Share an insight, caveat, or question.
Csanády et al. (1995) conducted a cohort in Dilated cardiomyopathy (n=240). Familial dilated cardiomyopathy vs. Non-familial dilated cardiomyopathy was evaluated on Six year survival (p=< 0.05). Familial dilated cardiomyopathy was associated with significantly worse six-year survival compared to non-familial forms (6% vs 23%, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: